MENU
REPL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Replimune Group (REPL) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

REPL is expected to report earnings to rise 12.19% to -76 cents per share on February 06

Replimune Group REPL Stock Earnings Reports
Q4'24
Est.
$-0.76
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.08
Q1'24
Missed
by $0.05
Q4'23
Beat
by $0.12
The last earnings report on November 12 showed earnings per share of -68 cents, beating the estimate of -81 cents. With 2.35M shares outstanding, the current market capitalization sits at 960.41M.
View a ticker or compare two or three
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
284
Web
https://www.replimune.com